Quince Therapeutics Partners with Cornerstone Capital Bank, Recognized for Builder Support Excellence
- Cornerstone Capital Bank was named 2024 Service Provider Partner of the Year by Shinn Builder Partnerships for outstanding contributions.
- The bank funded $2.2 billion in builder commitments in 2024, demonstrating robust growth and strategic partnerships.
- Cornerstone emphasizes positive client relationships and community engagement while maintaining a strong workplace culture and service excellence.
Cornerstone Capital Bank Sets New Standards in Builder Support Services
Cornerstone Capital Bank garners significant recognition for its exemplary contributions to the home-building industry by being named the 2024 Service Provider Partner of the Year by Shinn Builder Partnerships. This award, presented during the 19th Annual Networking Reception at the prestigious International Builders' Show, underscores Cornerstone's rapid ascent within the builder support sector since joining the Shinn network earlier this year. With a focus on delivering tailored financial solutions to over 1,600 private home builders across the United States, the bank has demonstrated its commitment to the industry and its clients.
Underlining its impact, Cornerstone Capital Bank has funded an impressive $2.2 billion in builder forward commitments in 2024 alone. This financial backing highlights not only the bank's robust growth but also its strategic approach to partnerships in the home-building ecosystem. Brian Wildermuth, Executive Vice President of Shinn Builder Partnerships, acknowledges the bank's swift integration and substantial contributions, which have solidified its reputation as a trusted partner for builders. The bank's comprehensive suite of services, including mortgage joint venture programs and advisory services, positions it as a pivotal player in a competitive landscape.
Lonnie Jenkins, Vice President of the Builder Division at Cornerstone, articulates the bank's vision of fostering relationships that extend beyond mere financial transactions. With a workforce of 1,500 dedicated employees based in Houston, Texas, Cornerstone is not only recognized for its financial acumen but also for its workplace culture, having earned accolades such as the Fortune Great Place to Work® certification. The bank's mission emphasizes making a positive difference in clients' lives, a commitment that resonates with its innovative approaches and responsive service in an evolving market.
In addition to its recent accolades, Cornerstone Capital Bank is making strides in community engagement and social responsibility, reinforcing its role as a leader in the industry. The bank's ongoing initiatives aim to provide builders with the necessary tools and support to navigate the complexities of the housing market effectively.
As Cornerstone Capital Bank continues to build on its success, its focus on nurturing collaborative relationships and delivering exceptional service remains at the forefront of its strategy, ensuring its pivotal role in shaping the future of home-building finance.
Related Cashu News

Bristol-Myers Squibb's Reclassification Enhances Growth Potential in Defensive Investment Strategy
Bristol-Myers Squibb Company (Ticker: BMY) undergoes a key reclassification across the Russell indexes, marking a transformative moment for the company. Moving to the Russell 1000 Defensive and Russel…

Vertex Pharmaceuticals' Casgevy Gains FDA Approval for Expanded Sickle Cell Disease Treatment Options
Vertex Pharmaceuticals (Ticker: VRTX) receives a significant boost in its ongoing battle against sickle cell disease with the recent FDA approval of an expanded label for its gene therapy product, Cas…

Gilead Sciences Gains FDA Approval for Trodelvy in First-Line Triple-Negative Breast Cancer Treatment
Gilead Sciences (Ticker: GILD) makes significant strides in oncology therapy with the recent approval of its drug Trodelvy for patients with unresectable or metastatic triple-negative breast cancer. T…

Merck Advances HIV Treatment and Faces Regulatory Scrutiny Amidst Market Success
Merck & Co. (Ticker: MRK) has recently made significant strides in the pharmaceutical landscape, particularly with its advancements in HIV treatment. The company's innovative drug, IDVYNSO, has receiv…